Rottenstein Law Group Unsure of Wisdom of Proposed FDA Device Review Arrangement

The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, has some misgivings about a reported proposed new arrangement for the evaluation of medical devices by the FDA. New York, NY (PRWEB) February 13, 2012 According to a February 2012, Bloomberg Businessweek report, in the next five years medical device manufacturers will pay twice as much to the U.S. Food and Drug Administration for “faster and more predictable evaluations.” “The pact with the Food
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations